Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor
about
Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor
description
scientific article published on 24 March 2020
@en
name
Preclinical Antimalarial Combi ...... a Hemozoin Formation Inhibitor
@en
type
label
Preclinical Antimalarial Combi ...... a Hemozoin Formation Inhibitor
@en
prefLabel
Preclinical Antimalarial Combi ...... a Hemozoin Formation Inhibitor
@en
P2093
P356
P1476
Preclinical Antimalarial Combi ...... a Hemozoin Formation Inhibitor
@en
P2093
Beatrice Greco
Brian Jonat
Christin Gumpp
Claude Oeuvray
David A Fidock
Lassina Badolo
Marla J Giddins
Satish K Dhingra
Xiaoyan Yin
P356
10.1128/AAC.02181-19
P577
2020-03-24T00:00:00Z